Share
3,090 Posts.
lightbulb Created with Sketch. 499
clock Created with Sketch. 07/09/22
13:05
Share
Originally posted by samfiodiving:
↑
Part of a post i was putting together Charmaine has just been going over some of this but looks like we are stepping back into a PH2b trial Up to 114 participants are to be enrolled (38 per treatment arm) with 108 participants expected to complete the trial. Additional trial details and timelines are outlined in the investor presentation lodged today with the ASX. As previously announced, The Phase IIb study aims to enrol and randomize 45 non-ambulant boys with DMD. Following the initial six-month regimen of either placebo, 25 mg or 50 mg once weekly, The Phase IIb/III clinical trial application submitted in Germany (BfArM) is undergoing evaluation. With the regulatory focus now directed to submission of the Phase IIb trial applications, no additional Phase IIb/III trial submissions are planned at this time
Expand
would you prefer us to sell out with a crappy deal to raise the funds? Or do a CR at 8c? This trial will potentially bring us to the same point as the 2b
